Abstract

Osteosarcoma (OS) is the most common form of primary bone cancer in humans. The early detection and subsequent control of metastasis has been challenging in OS. Lipids are important constituents of cells that maintain structural integrity that can be converted into lipid-signaling molecules and are reprogrammed in cancerous states. Here, we investigate the global lipidomic differences in metastatic (143B) and nonmetastatic (HOS) human OS cells as compared with normal fetal osteoblast cells (FOB) using lipidomics. We detect 15 distinct lipid classes in all three cell lines that included over 1,000 lipid species across various classes including phospholipids, sphingolipids and ceramides, glycolipids, and cholesterol. We identify a key class of lipids, diacylglycerols, which are overexpressed in metastatic OS cells as compared with their nonmetastatic or nontumorigenic counterparts. As a proof of concept, we show that blocking diacylglycerol synthesis reduces cellular viability and reduces cell migration in metastatic OS cells. Thus, the differentially regulated lipids identified in this study might aid in biomarker discovery, and the synthesis and metabolism of specific lipids could serve as future targets for therapeutic development.—Roy, J., P. Dibaeinia, T. M. Fan, S. Sinha, and A. Das. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

Original languageEnglish (US)
Pages (from-to)375-387
Number of pages13
JournalJournal of Lipid Research
Volume60
Issue number2
DOIs
StatePublished - Jan 1 2019

Fingerprint

Osteosarcoma
Lipids
Diglycerides
Bone Neoplasms
Sphingolipids
Ceramides
Glycolipids
Osteoblasts
Lipid Metabolism
Biomarkers
Structural integrity
Cell Movement
Metabolism
Phospholipids
Fans
Cholesterol
Bone
Neoplasm Metastasis
Cells
Cell Line

Keywords

  • Cholesterol
  • Diacylglycerol
  • Lipidomics
  • Mass spectrometry

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells. / Roy, Jahnabi; Dibaeinia, Payam; Fan, Timothy M; Sinha, Saurabh; Das, Aditi.

In: Journal of Lipid Research, Vol. 60, No. 2, 01.01.2019, p. 375-387.

Research output: Contribution to journalArticle

@article{646f6bb5176245b99f262d881b4961e9,
title = "Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells",
abstract = "Osteosarcoma (OS) is the most common form of primary bone cancer in humans. The early detection and subsequent control of metastasis has been challenging in OS. Lipids are important constituents of cells that maintain structural integrity that can be converted into lipid-signaling molecules and are reprogrammed in cancerous states. Here, we investigate the global lipidomic differences in metastatic (143B) and nonmetastatic (HOS) human OS cells as compared with normal fetal osteoblast cells (FOB) using lipidomics. We detect 15 distinct lipid classes in all three cell lines that included over 1,000 lipid species across various classes including phospholipids, sphingolipids and ceramides, glycolipids, and cholesterol. We identify a key class of lipids, diacylglycerols, which are overexpressed in metastatic OS cells as compared with their nonmetastatic or nontumorigenic counterparts. As a proof of concept, we show that blocking diacylglycerol synthesis reduces cellular viability and reduces cell migration in metastatic OS cells. Thus, the differentially regulated lipids identified in this study might aid in biomarker discovery, and the synthesis and metabolism of specific lipids could serve as future targets for therapeutic development.—Roy, J., P. Dibaeinia, T. M. Fan, S. Sinha, and A. Das. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.",
keywords = "Cholesterol, Diacylglycerol, Lipidomics, Mass spectrometry",
author = "Jahnabi Roy and Payam Dibaeinia and Fan, {Timothy M} and Saurabh Sinha and Aditi Das",
year = "2019",
month = "1",
day = "1",
doi = "10.1194/jlr.M088559",
language = "English (US)",
volume = "60",
pages = "375--387",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells

AU - Roy, Jahnabi

AU - Dibaeinia, Payam

AU - Fan, Timothy M

AU - Sinha, Saurabh

AU - Das, Aditi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Osteosarcoma (OS) is the most common form of primary bone cancer in humans. The early detection and subsequent control of metastasis has been challenging in OS. Lipids are important constituents of cells that maintain structural integrity that can be converted into lipid-signaling molecules and are reprogrammed in cancerous states. Here, we investigate the global lipidomic differences in metastatic (143B) and nonmetastatic (HOS) human OS cells as compared with normal fetal osteoblast cells (FOB) using lipidomics. We detect 15 distinct lipid classes in all three cell lines that included over 1,000 lipid species across various classes including phospholipids, sphingolipids and ceramides, glycolipids, and cholesterol. We identify a key class of lipids, diacylglycerols, which are overexpressed in metastatic OS cells as compared with their nonmetastatic or nontumorigenic counterparts. As a proof of concept, we show that blocking diacylglycerol synthesis reduces cellular viability and reduces cell migration in metastatic OS cells. Thus, the differentially regulated lipids identified in this study might aid in biomarker discovery, and the synthesis and metabolism of specific lipids could serve as future targets for therapeutic development.—Roy, J., P. Dibaeinia, T. M. Fan, S. Sinha, and A. Das. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

AB - Osteosarcoma (OS) is the most common form of primary bone cancer in humans. The early detection and subsequent control of metastasis has been challenging in OS. Lipids are important constituents of cells that maintain structural integrity that can be converted into lipid-signaling molecules and are reprogrammed in cancerous states. Here, we investigate the global lipidomic differences in metastatic (143B) and nonmetastatic (HOS) human OS cells as compared with normal fetal osteoblast cells (FOB) using lipidomics. We detect 15 distinct lipid classes in all three cell lines that included over 1,000 lipid species across various classes including phospholipids, sphingolipids and ceramides, glycolipids, and cholesterol. We identify a key class of lipids, diacylglycerols, which are overexpressed in metastatic OS cells as compared with their nonmetastatic or nontumorigenic counterparts. As a proof of concept, we show that blocking diacylglycerol synthesis reduces cellular viability and reduces cell migration in metastatic OS cells. Thus, the differentially regulated lipids identified in this study might aid in biomarker discovery, and the synthesis and metabolism of specific lipids could serve as future targets for therapeutic development.—Roy, J., P. Dibaeinia, T. M. Fan, S. Sinha, and A. Das. Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

KW - Cholesterol

KW - Diacylglycerol

KW - Lipidomics

KW - Mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=85060951282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060951282&partnerID=8YFLogxK

U2 - 10.1194/jlr.M088559

DO - 10.1194/jlr.M088559

M3 - Article

VL - 60

SP - 375

EP - 387

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 2

ER -